NB-598 Maleate is a potent and competitive squalene epoxidase inhibitor that suppresses triglyceride biosynthesis via the farnesol pathway; it significantly reduces total cholesterol levels in MIN6 cells and decreases cholesterol content in plasma membrane (PM), endoplasmic reticulum (ER), and secretory granules (SG); it inhibits sterol and sterol ester synthesis from [14C]acetate without affecting the synthesis of other lipids such as phospholipids (PL), free fatty acids (FFA), and triacylglycerol (TG); it reduces ACAT activity both in the absence and presence of exogenous liposomal cholesterol; it suppresses the secretion of cholesterol and triacylglycerol from HepG2 cells into the medium.